Scalp Cooling in MBC
NCT: NCT04986579 · RECRUITING
NCT IDNCT04986579
StatusRECRUITING
Start Date2021-10-07
Completion2030-06-01
SponsorDana-Farber Cancer Institute (OTHER)
First posted
Last updated
Brief Summary
This research is being done to compare rates of hair loss of people with metastatic breast who use scalp cooling versus those who do not use scalp cooling after receiving standard of care treatment with either sacituzumab govitecan, trastuzumab deruxtecan, or eribulin. The name of the study intervention involved in this study is: * Paxman Scalp Cooling System
Frequently Asked Questions
What is Scalp Cooling in MBC?
Scalp Cooling in MBC is a clinical trial registered under NCT04986579. Current status: RECRUITING.
What is the status of NCT04986579?
The current status of NCT04986579 (Scalp Cooling in MBC) is: RECRUITING.
When did Scalp Cooling in MBC start?
Scalp Cooling in MBC started on 2021-10-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.